Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

MyBioSource, a trusted global supplier of premium research reagents, offers five types of PCR kits, tailored to different experimental requirements. These ready-to-use kits include high-quality ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

Veterinary team develops molecular test to find hidden equine herpesvirus infections before they spread to other animals.

In a significant development in the fight against COVID-19, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting the virus. This landmark decision, announced last ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...

A significant number of Tuberculosis (TB) cases go undetected due to the limited sensitivity of smear microscopy, the most common diagnostic test for TB in India.